| ALENDRONIC ACID | Small molecule | periodontitis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| MINODRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate adenocarcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | sarcoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | radius fracture | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteogenesis imperfecta type 3 | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Ewing sarcoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | fibrous dysplasia | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone neoplasm | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | myelofibrosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | periodontal disorder | Farnesyl diphosphate synthase inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | metastatic malignant neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | prostate adenocarcinoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | nasopharyngeal neoplasm | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | leukemia | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Unknown status | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | giant cell tumor | Farnesyl diphosphate synthase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteitis deformans | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| PAMIDRONIC ACID | Small molecule | spondyloarthropathy | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | pain | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| PAMIDRONATE DISODIUM | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | ATC |
| ALENDRONIC ACID | Small molecule | asthma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| IBANDRONIC ACID | Small molecule | bone neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Thalassemia | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| IBANDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | pancreatic adenocarcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | metastatic prostate cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate adenocarcinoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | radius fracture | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteogenesis imperfecta type 4 | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | metabolic disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | primary myelofibrosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | lung neoplasm | Farnesyl diphosphate synthase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 1.0 | Terminated | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | menopause | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | pain | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | pain | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteitis deformans | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | polyostotic fibrous dysplasia | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | mesothelioma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | non-small cell lung carcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastatic malignant neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | leukemia | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | Spinal cord injury | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | HIV infection | Farnesyl diphosphate synthase inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | lymphoid neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | menopause | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Beta-thalassemia | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | non-small cell lung carcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 4.0 | Unknown status | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | depressive disorder | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | progeria | Farnesyl diphosphate synthase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | toxicity | Farnesyl diphosphate synthase inhibitor | 3.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | breast neoplasm | Farnesyl diphosphate synthase inhibitor | 1.0 | Terminated | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | lung cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | hepatocellular carcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | neuroblastoma | Farnesyl diphosphate synthase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone metastasis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | sarcoma | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | giant cell tumor | Farnesyl diphosphate synthase inhibitor | 3.0 | Recruiting | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastasis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed,FDA |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | non-small cell lung carcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | rheumatoid arthritis | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone metastasis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | kidney cancer | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | ATC |
| ZOLEDRONIC ACID | Small molecule | giant cell tumor | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | ankylosing spondylitis | Farnesyl diphosphate synthase inhibitor | 4.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | neuroblastoma | Farnesyl diphosphate synthase inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | lymphoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| PAMIDRONATE DISODIUM | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| RISEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | vitamin D deficiency | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | urogenital neoplasm | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | reflex sympathetic dystrophy | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone metastasis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | lung cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | lung cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | rheumatoid arthritis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | HIV infection | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | Low back pain | Farnesyl diphosphate synthase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | Back pain | Farnesyl diphosphate synthase inhibitor | 4.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | periodontitis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| PAMIDRONATE DISODIUM | Small molecule | SAPHO syndrome | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate carcinoma | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| PAMIDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | ATC |
| RISEDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | ATC |
| ALENDRONIC ACID | Small molecule | osteoarthritis, knee | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | non-Hodgkins lymphoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastasis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ALENDRONIC ACID | Small molecule | ovarian cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteitis deformans | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | plasmacytoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | metabolic disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | breast neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoarthritis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | tuberculosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Paget disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| RISEDRONATE SODIUM | Small molecule | lymphoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | kidney cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastatic malignant neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoarthritis, hip | Farnesyl diphosphate synthase inhibitor | 3.0 | Recruiting | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | sickle cell anemia | Farnesyl diphosphate synthase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| MINODRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteitis deformans | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | metastatic malignant neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | Reduced bone mineral density | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | osteonecrosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteonecrosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | osteoarthritis, knee | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone neoplasm | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | toxicity | Farnesyl diphosphate synthase inhibitor | 3.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteosarcoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | cervical adenocarcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| IBANDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | vitamin D deficiency | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | chondrosarcoma | Farnesyl diphosphate synthase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | SAPHO syndrome | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed,FDA |
| ZOLEDRONIC ACID | Small molecule | bone metastasis | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone fracture | Farnesyl diphosphate synthase inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | cystic fibrosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | pain | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | complex regional pain syndrome | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed,FDA |
| ZOLEDRONIC ACID | Small molecule | metastasis | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | primary peritoneal carcinoma | Farnesyl diphosphate synthase inhibitor | 0.5 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast neoplasm | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | renal osteodystrophy | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| MINODRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| PAMIDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastatic neoplasm | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | neuroblastoma | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| PAMIDRONATE DISODIUM | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | metastasis | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | age-related macular degeneration | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | pain | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Hutchinson-Gilford progeria syndrome | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | systemic lupus erythematosus | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | coronary stenosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | Paget disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | adenocarcinoma | Farnesyl diphosphate synthase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Spinal cord injury | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoarthritis, hip | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Low back pain | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | non-small cell lung carcinoma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | Abdominal pain | Farnesyl diphosphate synthase inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 4.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 3.0 | Terminated | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | renal cell carcinoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast ductal carcinoma in situ | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteitis deformans | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | allergic disease | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone fracture | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | osteitis deformans | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PAMIDRONATE DISODIUM | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | hyperparathyroidism | Farnesyl diphosphate synthase inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate adenocarcinoma | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | periodontitis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | aortic stenosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | cirrhosis of liver | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastatic malignant neoplasm | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastatic malignant neoplasm | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | renal osteodystrophy | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| RISEDRONATE SODIUM | Small molecule | Paget disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| RISEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteitis deformans | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ALENDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed,FDA |
| IBANDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | HIV infection | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | osteonecrosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | cervical cancer | Farnesyl diphosphate synthase inhibitor | 1.0 | Terminated | ClinicalTrials |
| MINODRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| PAMIDRONATE DISODIUM | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | leiomyosarcoma | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MINODRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| IBANDRONATE SODIUM | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| ZOLEDRONIC ACID | Small molecule | osteonecrosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| IBANDRONIC ACID | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Unknown status | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | hepatitis B virus infection | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ALENDRONIC ACID | Small molecule | osteonecrosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Unknown status | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone disease | Farnesyl diphosphate synthase inhibitor | 4.0 | - | ATC |
| RISEDRONIC ACID | Small molecule | Back pain | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | prostate cancer | Farnesyl diphosphate synthase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 2.0 | Completed | ClinicalTrials |
| PAMIDRONIC ACID | Small molecule | Low back pain | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | multiple myeloma | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | metastatic prostate cancer | Farnesyl diphosphate synthase inhibitor | 1.0 | Completed | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | bone fracture | Farnesyl diphosphate synthase inhibitor | 4.0 | Terminated | ClinicalTrials |
| ZOLEDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | osteogenesis imperfecta | Farnesyl diphosphate synthase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| RISEDRONIC ACID | Small molecule | postmenopausal osteoporosis | Farnesyl diphosphate synthase inhibitor | 4.0 | - | DailyMed |
| PAMIDRONIC ACID | Small molecule | Osteopenia | Farnesyl diphosphate synthase inhibitor | 4.0 | Completed | ClinicalTrials |
| ALENDRONATE SODIUM | Small molecule | breast cancer | Farnesyl diphosphate synthase inhibitor | 3.0 | Completed | ClinicalTrials |